nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—CYP1A2—Dacarbazine—muscle cancer	0.12	0.182	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.115	0.174	CbGbCtD
Aprepitant—CYP3A7—Vincristine—muscle cancer	0.115	0.174	CbGbCtD
Aprepitant—CYP3A5—Vincristine—muscle cancer	0.0864	0.131	CbGbCtD
Aprepitant—CYP3A5—Etoposide—muscle cancer	0.0792	0.12	CbGbCtD
Aprepitant—CYP1A2—Etoposide—muscle cancer	0.0589	0.0892	CbGbCtD
Aprepitant—CYP3A4—Vincristine—muscle cancer	0.0337	0.051	CbGbCtD
Aprepitant—CYP3A4—Etoposide—muscle cancer	0.0309	0.0467	CbGbCtD
Aprepitant—CYP3A4—Doxorubicin—muscle cancer	0.0211	0.0319	CbGbCtD
Aprepitant—Breast disorder—Methotrexate—muscle cancer	0.00058	0.00171	CcSEcCtD
Aprepitant—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000578	0.00171	CcSEcCtD
Aprepitant—Abdominal pain—Dactinomycin—muscle cancer	0.000575	0.0017	CcSEcCtD
Aprepitant—Body temperature increased—Dactinomycin—muscle cancer	0.000575	0.0017	CcSEcCtD
Aprepitant—Loss of consciousness—Etoposide—muscle cancer	0.000567	0.00167	CcSEcCtD
Aprepitant—Lethargy—Doxorubicin—muscle cancer	0.000567	0.00167	CcSEcCtD
Aprepitant—Decreased appetite—Vincristine—muscle cancer	0.000565	0.00167	CcSEcCtD
Aprepitant—Cough—Etoposide—muscle cancer	0.000563	0.00166	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Vincristine—muscle cancer	0.000561	0.00166	CcSEcCtD
Aprepitant—Fatigue—Vincristine—muscle cancer	0.000561	0.00165	CcSEcCtD
Aprepitant—Convulsion—Etoposide—muscle cancer	0.000559	0.00165	CcSEcCtD
Aprepitant—Hyponatraemia—Doxorubicin—muscle cancer	0.000558	0.00165	CcSEcCtD
Aprepitant—Hypertension—Etoposide—muscle cancer	0.000557	0.00164	CcSEcCtD
Aprepitant—Pain—Vincristine—muscle cancer	0.000556	0.00164	CcSEcCtD
Aprepitant—Constipation—Vincristine—muscle cancer	0.000556	0.00164	CcSEcCtD
Aprepitant—Osteoarthritis—Doxorubicin—muscle cancer	0.000556	0.00164	CcSEcCtD
Aprepitant—Chest pain—Etoposide—muscle cancer	0.00055	0.00162	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000546	0.00161	CcSEcCtD
Aprepitant—Discomfort—Etoposide—muscle cancer	0.000543	0.0016	CcSEcCtD
Aprepitant—Hypersensitivity—Dactinomycin—muscle cancer	0.000536	0.00158	CcSEcCtD
Aprepitant—Abdominal discomfort—Methotrexate—muscle cancer	0.000532	0.00157	CcSEcCtD
Aprepitant—Gastrointestinal pain—Vincristine—muscle cancer	0.000532	0.00157	CcSEcCtD
Aprepitant—Confusional state—Etoposide—muscle cancer	0.000531	0.00157	CcSEcCtD
Aprepitant—Anaphylactic shock—Etoposide—muscle cancer	0.000527	0.00155	CcSEcCtD
Aprepitant—Infection—Etoposide—muscle cancer	0.000523	0.00154	CcSEcCtD
Aprepitant—Asthenia—Dactinomycin—muscle cancer	0.000522	0.00154	CcSEcCtD
Aprepitant—Blood creatinine increased—Doxorubicin—muscle cancer	0.000521	0.00154	CcSEcCtD
Aprepitant—Dysuria—Methotrexate—muscle cancer	0.000519	0.00153	CcSEcCtD
Aprepitant—Neutropenia—Methotrexate—muscle cancer	0.000519	0.00153	CcSEcCtD
Aprepitant—Dehydration—Doxorubicin—muscle cancer	0.000517	0.00153	CcSEcCtD
Aprepitant—Thrombocytopenia—Etoposide—muscle cancer	0.000516	0.00152	CcSEcCtD
Aprepitant—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000516	0.00152	CcSEcCtD
Aprepitant—Tachycardia—Etoposide—muscle cancer	0.000514	0.00152	CcSEcCtD
Aprepitant—Abdominal pain—Vincristine—muscle cancer	0.000514	0.00152	CcSEcCtD
Aprepitant—Body temperature increased—Vincristine—muscle cancer	0.000514	0.00152	CcSEcCtD
Aprepitant—Skin disorder—Etoposide—muscle cancer	0.000512	0.00151	CcSEcCtD
Aprepitant—Hyperhidrosis—Etoposide—muscle cancer	0.000509	0.0015	CcSEcCtD
Aprepitant—Abdominal pain upper—Doxorubicin—muscle cancer	0.000508	0.0015	CcSEcCtD
Aprepitant—Photosensitivity reaction—Methotrexate—muscle cancer	0.000506	0.00149	CcSEcCtD
Aprepitant—Hypokalaemia—Doxorubicin—muscle cancer	0.000506	0.00149	CcSEcCtD
Aprepitant—Breast disorder—Doxorubicin—muscle cancer	0.000502	0.00148	CcSEcCtD
Aprepitant—Anorexia—Etoposide—muscle cancer	0.000502	0.00148	CcSEcCtD
Aprepitant—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000501	0.00148	CcSEcCtD
Aprepitant—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000501	0.00148	CcSEcCtD
Aprepitant—Diarrhoea—Dactinomycin—muscle cancer	0.000498	0.00147	CcSEcCtD
Aprepitant—Pneumonia—Methotrexate—muscle cancer	0.000498	0.00147	CcSEcCtD
Aprepitant—Infestation NOS—Methotrexate—muscle cancer	0.000495	0.00146	CcSEcCtD
Aprepitant—Infestation—Methotrexate—muscle cancer	0.000495	0.00146	CcSEcCtD
Aprepitant—Hypotension—Etoposide—muscle cancer	0.000492	0.00145	CcSEcCtD
Aprepitant—Gastritis—Doxorubicin—muscle cancer	0.000492	0.00145	CcSEcCtD
Aprepitant—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00049	0.00145	CcSEcCtD
Aprepitant—Muscular weakness—Doxorubicin—muscle cancer	0.00049	0.00145	CcSEcCtD
Aprepitant—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00049	0.00145	CcSEcCtD
Aprepitant—Renal failure—Methotrexate—muscle cancer	0.000486	0.00143	CcSEcCtD
Aprepitant—Abdominal distension—Doxorubicin—muscle cancer	0.000484	0.00143	CcSEcCtD
Aprepitant—Stomatitis—Methotrexate—muscle cancer	0.000482	0.00142	CcSEcCtD
Aprepitant—Conjunctivitis—Methotrexate—muscle cancer	0.000481	0.00142	CcSEcCtD
Aprepitant—Dysphagia—Doxorubicin—muscle cancer	0.00048	0.00142	CcSEcCtD
Aprepitant—Hypersensitivity—Vincristine—muscle cancer	0.000479	0.00141	CcSEcCtD
Aprepitant—Paraesthesia—Etoposide—muscle cancer	0.000473	0.0014	CcSEcCtD
Aprepitant—Haematuria—Methotrexate—muscle cancer	0.000472	0.00139	CcSEcCtD
Aprepitant—Dyspnoea—Etoposide—muscle cancer	0.00047	0.00139	CcSEcCtD
Aprepitant—Somnolence—Etoposide—muscle cancer	0.000468	0.00138	CcSEcCtD
Aprepitant—Asthenia—Vincristine—muscle cancer	0.000467	0.00138	CcSEcCtD
Aprepitant—Vomiting—Dactinomycin—muscle cancer	0.000463	0.00137	CcSEcCtD
Aprepitant—Rash—Dactinomycin—muscle cancer	0.000459	0.00135	CcSEcCtD
Aprepitant—Decreased appetite—Etoposide—muscle cancer	0.000458	0.00135	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Etoposide—muscle cancer	0.000455	0.00134	CcSEcCtD
Aprepitant—Fatigue—Etoposide—muscle cancer	0.000454	0.00134	CcSEcCtD
Aprepitant—Constipation—Etoposide—muscle cancer	0.00045	0.00133	CcSEcCtD
Aprepitant—Pain—Etoposide—muscle cancer	0.00045	0.00133	CcSEcCtD
Aprepitant—Dysuria—Doxorubicin—muscle cancer	0.000449	0.00133	CcSEcCtD
Aprepitant—Neutropenia—Doxorubicin—muscle cancer	0.000449	0.00133	CcSEcCtD
Aprepitant—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000447	0.00132	CcSEcCtD
Aprepitant—Diarrhoea—Vincristine—muscle cancer	0.000445	0.00131	CcSEcCtD
Aprepitant—Pollakiuria—Doxorubicin—muscle cancer	0.000444	0.00131	CcSEcCtD
Aprepitant—Pharyngitis—Methotrexate—muscle cancer	0.000441	0.0013	CcSEcCtD
Aprepitant—Urinary tract disorder—Methotrexate—muscle cancer	0.000439	0.00129	CcSEcCtD
Aprepitant—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000439	0.00129	CcSEcCtD
Aprepitant—Weight increased—Doxorubicin—muscle cancer	0.000437	0.00129	CcSEcCtD
Aprepitant—Urethral disorder—Methotrexate—muscle cancer	0.000435	0.00128	CcSEcCtD
Aprepitant—Weight decreased—Doxorubicin—muscle cancer	0.000435	0.00128	CcSEcCtD
Aprepitant—Feeling abnormal—Etoposide—muscle cancer	0.000434	0.00128	CcSEcCtD
Aprepitant—Hyperglycaemia—Doxorubicin—muscle cancer	0.000433	0.00128	CcSEcCtD
Aprepitant—Nausea—Dactinomycin—muscle cancer	0.000432	0.00128	CcSEcCtD
Aprepitant—Pneumonia—Doxorubicin—muscle cancer	0.000431	0.00127	CcSEcCtD
Aprepitant—Gastrointestinal pain—Etoposide—muscle cancer	0.000431	0.00127	CcSEcCtD
Aprepitant—Dizziness—Vincristine—muscle cancer	0.00043	0.00127	CcSEcCtD
Aprepitant—Infestation NOS—Doxorubicin—muscle cancer	0.000428	0.00126	CcSEcCtD
Aprepitant—Infestation—Doxorubicin—muscle cancer	0.000428	0.00126	CcSEcCtD
Aprepitant—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000425	0.00125	CcSEcCtD
Aprepitant—Renal failure—Doxorubicin—muscle cancer	0.000421	0.00124	CcSEcCtD
Aprepitant—Erythema multiforme—Methotrexate—muscle cancer	0.00042	0.00124	CcSEcCtD
Aprepitant—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00042	0.00124	CcSEcCtD
Aprepitant—Urticaria—Etoposide—muscle cancer	0.000418	0.00123	CcSEcCtD
Aprepitant—Stomatitis—Doxorubicin—muscle cancer	0.000418	0.00123	CcSEcCtD
Aprepitant—Body temperature increased—Etoposide—muscle cancer	0.000416	0.00123	CcSEcCtD
Aprepitant—Abdominal pain—Etoposide—muscle cancer	0.000416	0.00123	CcSEcCtD
Aprepitant—Conjunctivitis—Doxorubicin—muscle cancer	0.000416	0.00123	CcSEcCtD
Aprepitant—Urinary tract infection—Doxorubicin—muscle cancer	0.000416	0.00123	CcSEcCtD
Aprepitant—Eye disorder—Methotrexate—muscle cancer	0.000415	0.00122	CcSEcCtD
Aprepitant—Tinnitus—Methotrexate—muscle cancer	0.000414	0.00122	CcSEcCtD
Aprepitant—Vomiting—Vincristine—muscle cancer	0.000413	0.00122	CcSEcCtD
Aprepitant—Cardiac disorder—Methotrexate—muscle cancer	0.000412	0.00122	CcSEcCtD
Aprepitant—Rash—Vincristine—muscle cancer	0.00041	0.00121	CcSEcCtD
Aprepitant—Dermatitis—Vincristine—muscle cancer	0.00041	0.00121	CcSEcCtD
Aprepitant—Haematuria—Doxorubicin—muscle cancer	0.000408	0.00121	CcSEcCtD
Aprepitant—Headache—Vincristine—muscle cancer	0.000407	0.0012	CcSEcCtD
Aprepitant—Angiopathy—Methotrexate—muscle cancer	0.000403	0.00119	CcSEcCtD
Aprepitant—Immune system disorder—Methotrexate—muscle cancer	0.000401	0.00118	CcSEcCtD
Aprepitant—Mediastinal disorder—Methotrexate—muscle cancer	0.0004	0.00118	CcSEcCtD
Aprepitant—Chills—Methotrexate—muscle cancer	0.000399	0.00118	CcSEcCtD
Aprepitant—Alopecia—Methotrexate—muscle cancer	0.000392	0.00116	CcSEcCtD
Aprepitant—Bradycardia—Doxorubicin—muscle cancer	0.000392	0.00116	CcSEcCtD
Aprepitant—Mental disorder—Methotrexate—muscle cancer	0.000389	0.00115	CcSEcCtD
Aprepitant—Hypersensitivity—Etoposide—muscle cancer	0.000388	0.00115	CcSEcCtD
Aprepitant—Erythema—Methotrexate—muscle cancer	0.000387	0.00114	CcSEcCtD
Aprepitant—Malnutrition—Methotrexate—muscle cancer	0.000387	0.00114	CcSEcCtD
Aprepitant—Nausea—Vincristine—muscle cancer	0.000386	0.00114	CcSEcCtD
Aprepitant—Hypoaesthesia—Doxorubicin—muscle cancer	0.000383	0.00113	CcSEcCtD
Aprepitant—Pharyngitis—Doxorubicin—muscle cancer	0.000382	0.00113	CcSEcCtD
Aprepitant—Urinary tract disorder—Doxorubicin—muscle cancer	0.00038	0.00112	CcSEcCtD
Aprepitant—Dysgeusia—Methotrexate—muscle cancer	0.000379	0.00112	CcSEcCtD
Aprepitant—Asthenia—Etoposide—muscle cancer	0.000378	0.00112	CcSEcCtD
Aprepitant—Connective tissue disorder—Doxorubicin—muscle cancer	0.000378	0.00112	CcSEcCtD
Aprepitant—Urethral disorder—Doxorubicin—muscle cancer	0.000377	0.00111	CcSEcCtD
Aprepitant—Back pain—Methotrexate—muscle cancer	0.000374	0.0011	CcSEcCtD
Aprepitant—Pruritus—Etoposide—muscle cancer	0.000373	0.0011	CcSEcCtD
Aprepitant—Erythema multiforme—Doxorubicin—muscle cancer	0.000364	0.00107	CcSEcCtD
Aprepitant—Diarrhoea—Etoposide—muscle cancer	0.00036	0.00106	CcSEcCtD
Aprepitant—Eye disorder—Doxorubicin—muscle cancer	0.000359	0.00106	CcSEcCtD
Aprepitant—Ill-defined disorder—Methotrexate—muscle cancer	0.000359	0.00106	CcSEcCtD
Aprepitant—Tinnitus—Doxorubicin—muscle cancer	0.000359	0.00106	CcSEcCtD
Aprepitant—Anaemia—Methotrexate—muscle cancer	0.000357	0.00105	CcSEcCtD
Aprepitant—Cardiac disorder—Doxorubicin—muscle cancer	0.000357	0.00105	CcSEcCtD
Aprepitant—Flushing—Doxorubicin—muscle cancer	0.000357	0.00105	CcSEcCtD
Aprepitant—Angiopathy—Doxorubicin—muscle cancer	0.000349	0.00103	CcSEcCtD
Aprepitant—Malaise—Methotrexate—muscle cancer	0.000349	0.00103	CcSEcCtD
Aprepitant—Dizziness—Etoposide—muscle cancer	0.000348	0.00103	CcSEcCtD
Aprepitant—Immune system disorder—Doxorubicin—muscle cancer	0.000347	0.00102	CcSEcCtD
Aprepitant—Mediastinal disorder—Doxorubicin—muscle cancer	0.000347	0.00102	CcSEcCtD
Aprepitant—Chills—Doxorubicin—muscle cancer	0.000345	0.00102	CcSEcCtD
Aprepitant—Alopecia—Doxorubicin—muscle cancer	0.00034	0.001	CcSEcCtD
Aprepitant—Cough—Methotrexate—muscle cancer	0.000337	0.000995	CcSEcCtD
Aprepitant—Mental disorder—Doxorubicin—muscle cancer	0.000337	0.000994	CcSEcCtD
Aprepitant—Convulsion—Methotrexate—muscle cancer	0.000335	0.000988	CcSEcCtD
Aprepitant—Vomiting—Etoposide—muscle cancer	0.000335	0.000988	CcSEcCtD
Aprepitant—Malnutrition—Doxorubicin—muscle cancer	0.000335	0.000988	CcSEcCtD
Aprepitant—Erythema—Doxorubicin—muscle cancer	0.000335	0.000988	CcSEcCtD
Aprepitant—Rash—Etoposide—muscle cancer	0.000332	0.00098	CcSEcCtD
Aprepitant—Dermatitis—Etoposide—muscle cancer	0.000332	0.000979	CcSEcCtD
Aprepitant—Headache—Etoposide—muscle cancer	0.00033	0.000974	CcSEcCtD
Aprepitant—Flatulence—Doxorubicin—muscle cancer	0.00033	0.000973	CcSEcCtD
Aprepitant—Arthralgia—Methotrexate—muscle cancer	0.000329	0.000971	CcSEcCtD
Aprepitant—Chest pain—Methotrexate—muscle cancer	0.000329	0.000971	CcSEcCtD
Aprepitant—Myalgia—Methotrexate—muscle cancer	0.000329	0.000971	CcSEcCtD
Aprepitant—Dysgeusia—Doxorubicin—muscle cancer	0.000328	0.000967	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000327	0.000965	CcSEcCtD
Aprepitant—Discomfort—Methotrexate—muscle cancer	0.000325	0.00096	CcSEcCtD
Aprepitant—Back pain—Doxorubicin—muscle cancer	0.000324	0.000955	CcSEcCtD
Aprepitant—Muscle spasms—Doxorubicin—muscle cancer	0.000322	0.00095	CcSEcCtD
Aprepitant—Confusional state—Methotrexate—muscle cancer	0.000318	0.000939	CcSEcCtD
Aprepitant—Anaphylactic shock—Methotrexate—muscle cancer	0.000316	0.000931	CcSEcCtD
Aprepitant—Infection—Methotrexate—muscle cancer	0.000313	0.000925	CcSEcCtD
Aprepitant—Nausea—Etoposide—muscle cancer	0.000313	0.000923	CcSEcCtD
Aprepitant—Ill-defined disorder—Doxorubicin—muscle cancer	0.000311	0.000917	CcSEcCtD
Aprepitant—Nervous system disorder—Methotrexate—muscle cancer	0.000309	0.000913	CcSEcCtD
Aprepitant—Anaemia—Doxorubicin—muscle cancer	0.000309	0.000913	CcSEcCtD
Aprepitant—Thrombocytopenia—Methotrexate—muscle cancer	0.000309	0.000912	CcSEcCtD
Aprepitant—Skin disorder—Methotrexate—muscle cancer	0.000306	0.000904	CcSEcCtD
Aprepitant—Hyperhidrosis—Methotrexate—muscle cancer	0.000305	0.0009	CcSEcCtD
Aprepitant—Malaise—Doxorubicin—muscle cancer	0.000302	0.000891	CcSEcCtD
Aprepitant—Anorexia—Methotrexate—muscle cancer	0.000301	0.000887	CcSEcCtD
Aprepitant—Syncope—Doxorubicin—muscle cancer	0.0003	0.000886	CcSEcCtD
Aprepitant—Palpitations—Doxorubicin—muscle cancer	0.000296	0.000873	CcSEcCtD
Aprepitant—Hypotension—Methotrexate—muscle cancer	0.000295	0.00087	CcSEcCtD
Aprepitant—Loss of consciousness—Doxorubicin—muscle cancer	0.000294	0.000868	CcSEcCtD
Aprepitant—Cough—Doxorubicin—muscle cancer	0.000292	0.000862	CcSEcCtD
Aprepitant—Convulsion—Doxorubicin—muscle cancer	0.00029	0.000856	CcSEcCtD
Aprepitant—Hypertension—Doxorubicin—muscle cancer	0.000289	0.000853	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000287	0.000848	CcSEcCtD
Aprepitant—Insomnia—Methotrexate—muscle cancer	0.000285	0.000842	CcSEcCtD
Aprepitant—Myalgia—Doxorubicin—muscle cancer	0.000285	0.000841	CcSEcCtD
Aprepitant—Chest pain—Doxorubicin—muscle cancer	0.000285	0.000841	CcSEcCtD
Aprepitant—Arthralgia—Doxorubicin—muscle cancer	0.000285	0.000841	CcSEcCtD
Aprepitant—Anxiety—Doxorubicin—muscle cancer	0.000284	0.000838	CcSEcCtD
Aprepitant—Paraesthesia—Methotrexate—muscle cancer	0.000283	0.000836	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000283	0.000835	CcSEcCtD
Aprepitant—Discomfort—Doxorubicin—muscle cancer	0.000282	0.000831	CcSEcCtD
Aprepitant—Dyspnoea—Methotrexate—muscle cancer	0.000281	0.00083	CcSEcCtD
Aprepitant—Somnolence—Methotrexate—muscle cancer	0.000281	0.000828	CcSEcCtD
Aprepitant—Dry mouth—Doxorubicin—muscle cancer	0.000279	0.000822	CcSEcCtD
Aprepitant—Dyspepsia—Methotrexate—muscle cancer	0.000278	0.00082	CcSEcCtD
Aprepitant—Confusional state—Doxorubicin—muscle cancer	0.000275	0.000813	CcSEcCtD
Aprepitant—Decreased appetite—Methotrexate—muscle cancer	0.000274	0.000809	CcSEcCtD
Aprepitant—Anaphylactic shock—Doxorubicin—muscle cancer	0.000273	0.000806	CcSEcCtD
Aprepitant—Oedema—Doxorubicin—muscle cancer	0.000273	0.000806	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000272	0.000804	CcSEcCtD
Aprepitant—Fatigue—Methotrexate—muscle cancer	0.000272	0.000803	CcSEcCtD
Aprepitant—Infection—Doxorubicin—muscle cancer	0.000271	0.000801	CcSEcCtD
Aprepitant—Pain—Methotrexate—muscle cancer	0.00027	0.000796	CcSEcCtD
Aprepitant—Shock—Doxorubicin—muscle cancer	0.000269	0.000793	CcSEcCtD
Aprepitant—Nervous system disorder—Doxorubicin—muscle cancer	0.000268	0.000791	CcSEcCtD
Aprepitant—Thrombocytopenia—Doxorubicin—muscle cancer	0.000268	0.000789	CcSEcCtD
Aprepitant—Tachycardia—Doxorubicin—muscle cancer	0.000267	0.000787	CcSEcCtD
Aprepitant—Skin disorder—Doxorubicin—muscle cancer	0.000265	0.000783	CcSEcCtD
Aprepitant—Hyperhidrosis—Doxorubicin—muscle cancer	0.000264	0.000779	CcSEcCtD
Aprepitant—Anorexia—Doxorubicin—muscle cancer	0.00026	0.000768	CcSEcCtD
Aprepitant—Feeling abnormal—Methotrexate—muscle cancer	0.00026	0.000767	CcSEcCtD
Aprepitant—Gastrointestinal pain—Methotrexate—muscle cancer	0.000258	0.000761	CcSEcCtD
Aprepitant—Hypotension—Doxorubicin—muscle cancer	0.000255	0.000753	CcSEcCtD
Aprepitant—Urticaria—Methotrexate—muscle cancer	0.000251	0.00074	CcSEcCtD
Aprepitant—Body temperature increased—Methotrexate—muscle cancer	0.000249	0.000736	CcSEcCtD
Aprepitant—Abdominal pain—Methotrexate—muscle cancer	0.000249	0.000736	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000249	0.000734	CcSEcCtD
Aprepitant—Insomnia—Doxorubicin—muscle cancer	0.000247	0.000729	CcSEcCtD
Aprepitant—Paraesthesia—Doxorubicin—muscle cancer	0.000245	0.000724	CcSEcCtD
Aprepitant—Dyspnoea—Doxorubicin—muscle cancer	0.000244	0.000719	CcSEcCtD
Aprepitant—Somnolence—Doxorubicin—muscle cancer	0.000243	0.000717	CcSEcCtD
Aprepitant—Dyspepsia—Doxorubicin—muscle cancer	0.000241	0.00071	CcSEcCtD
Aprepitant—Decreased appetite—Doxorubicin—muscle cancer	0.000238	0.000701	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000236	0.000696	CcSEcCtD
Aprepitant—Fatigue—Doxorubicin—muscle cancer	0.000236	0.000695	CcSEcCtD
Aprepitant—Pain—Doxorubicin—muscle cancer	0.000234	0.000689	CcSEcCtD
Aprepitant—Constipation—Doxorubicin—muscle cancer	0.000234	0.000689	CcSEcCtD
Aprepitant—Hypersensitivity—Methotrexate—muscle cancer	0.000232	0.000686	CcSEcCtD
Aprepitant—Asthenia—Methotrexate—muscle cancer	0.000226	0.000668	CcSEcCtD
Aprepitant—Feeling abnormal—Doxorubicin—muscle cancer	0.000225	0.000664	CcSEcCtD
Aprepitant—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000223	0.000659	CcSEcCtD
Aprepitant—Pruritus—Methotrexate—muscle cancer	0.000223	0.000659	CcSEcCtD
Aprepitant—Urticaria—Doxorubicin—muscle cancer	0.000217	0.00064	CcSEcCtD
Aprepitant—Abdominal pain—Doxorubicin—muscle cancer	0.000216	0.000637	CcSEcCtD
Aprepitant—Body temperature increased—Doxorubicin—muscle cancer	0.000216	0.000637	CcSEcCtD
Aprepitant—Diarrhoea—Methotrexate—muscle cancer	0.000216	0.000637	CcSEcCtD
Aprepitant—Dizziness—Methotrexate—muscle cancer	0.000209	0.000616	CcSEcCtD
Aprepitant—Hypersensitivity—Doxorubicin—muscle cancer	0.000201	0.000594	CcSEcCtD
Aprepitant—Vomiting—Methotrexate—muscle cancer	0.000201	0.000592	CcSEcCtD
Aprepitant—Rash—Methotrexate—muscle cancer	0.000199	0.000587	CcSEcCtD
Aprepitant—Dermatitis—Methotrexate—muscle cancer	0.000199	0.000586	CcSEcCtD
Aprepitant—Headache—Methotrexate—muscle cancer	0.000198	0.000583	CcSEcCtD
Aprepitant—Asthenia—Doxorubicin—muscle cancer	0.000196	0.000578	CcSEcCtD
Aprepitant—Pruritus—Doxorubicin—muscle cancer	0.000193	0.00057	CcSEcCtD
Aprepitant—Nausea—Methotrexate—muscle cancer	0.000187	0.000553	CcSEcCtD
Aprepitant—Diarrhoea—Doxorubicin—muscle cancer	0.000187	0.000552	CcSEcCtD
Aprepitant—Dizziness—Doxorubicin—muscle cancer	0.000181	0.000533	CcSEcCtD
Aprepitant—Vomiting—Doxorubicin—muscle cancer	0.000174	0.000513	CcSEcCtD
Aprepitant—Rash—Doxorubicin—muscle cancer	0.000172	0.000508	CcSEcCtD
Aprepitant—Dermatitis—Doxorubicin—muscle cancer	0.000172	0.000508	CcSEcCtD
Aprepitant—Headache—Doxorubicin—muscle cancer	0.000171	0.000505	CcSEcCtD
Aprepitant—Nausea—Doxorubicin—muscle cancer	0.000162	0.000479	CcSEcCtD
